Home Page > ANTIBODY > POLYCLONAL ANTIBODY > Goat Polyclonal Antibodies >  Goat anti-CCL3 and CCL3L1 Antibody

Goat anti-CCL3 and CCL3L1 Antibody
Item#:
dAP-0691
Size Price Quantity
50.0 ug $310.00
Goat anti-CCL3 and CCL3L1 Antibody
Principle Name CCL3 and CCL3L1
Official Symbol CCL3L1; CCL3
All Name and Symbols CCL3; chemokine (C-C motif) ligand 3; G0S19-1; LD78ALPHA; MIP-1-alpha; MIP1A; SCYA3; LD78 alpha beta; Small inducible cytokine A3; small inducible cytokine A3 (homologous to mouse Mip-1a); CCL3L1; LD78; 464.2; SCYA3L; G0S19-2; SCYA3L1; D17S1718; LD78BETA;
Accession Number(s) NP_002974.1; NP_066286.1
Peptide Sequence EWVQKYVSDLELSA, is from C Terminus
Human Gene ID(s) 6348; 6349
Non-Human GeneID(s)
Important Comments Please note this product is expected to recognize the products of 2 different genes which are almost identical.
Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied As lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.
Applications Pep ELISA
Tested Species
Peptide ELISA antibody detection limit dilution 1 to 32000.
Western Blot Preliminary experiments gave bands at approx 26+28kDa (doublet) and 40kDa in Human Bone Marrow and Spleen lysates after 0.1µg/ml antibody staining.The 26+28kDa doublet was also found in Human Lymph Node and in Tonsil lysates. Please note th
Reference(s) Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK. The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility. Science. 2005 Jan 6; [Epub ahead of print] .PMID

ANGIO-PROTEOMIE, ALL RIGHTS RESERVED